MedPath

Effect of Human Menopausal Gonadotrophin (HMG) therapy on fertility of infertile males

Phase 2
Recruiting
Conditions
Infertility.
Male infertility
Registration Number
IRCT20150317021497N5
Lead Sponsor
Rafsanjan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Male
Target Recruitment
30
Inclusion Criteria

unexplained infertility
2 years since marriage
Age 25-40 years
Men

Exclusion Criteria

Wife Infertility

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Frequency of fertility. Timepoint: 3 months after beginning drug use. Method of measurement: Checklist.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath